💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for TIC

No earnings history available for this symbol.

📰 Related News & Research

• Supernus Pharmaceuticals Acquires NV-5138 (SPN-820) Compound from Navitor Pharmaceuticals in Asset Purchase Agreement
  April 8, 2026
  

  Supernus Pharmaceuticals, Inc. Announces Entry into Asset Pu...

• Richtech Robotics Signs Purchase Agreement for Las Vegas Facility at 9530 S. Rainbow Blvd
  April 8, 2026
  

  Richtech Robotics Inc. Enters Material Asset Purchase Agreem...

• Zhejiang Hisun Pharmaceutical (海正药业) 2025 Annual Report Summary: Business Overview, Financial Data, and Strategic Highlights
  April 8, 2026
  

  浙江海正药业股份有限公司2025年年度报告详细解读 浙江海正药业股份有限公司2025年年度报告详细解读 一、业绩概览...

• Zhejiang Hisun Pharmaceutical Co., Ltd. 2025 Annual Report: Financial Performance, Business Overview, and Future Strategy
  April 8, 2026
  

  浙江海正药业股份有限公司2025年年度报告深度解读：业绩亮点、风险事项及投资者须知 一、业绩亮点及经营分析 营收...

• Bluejay Diagnostics Nears Completion of SYMON-II Clinical Trial with 624 Patient Enrollments for Symphony IL-6 Sepsis Test
  April 7, 2026
  

  Bluejay Diagnostics Reaches Key Enrollment Milestone in SYMO...

• Transportation and Logistics Systems, Inc. Signs Definitive Agreement to Acquire Patriot Glass Solutions, Advancing Safety and Security Technology Strategy
  April 7, 2026
  

  Transportation & Logistics Systems, Inc. Announces Major Acq...

• Inhibikase Therapeutics Enrolls First Patient in Global Phase 3 IMPROVE-PAH Study for Pulmonary Arterial Hypertension Treatment 1
  April 7, 2026
  

  Inhibikase Therapeutics Reports Key Milestone in PAH Program...

• Corbus Pharmaceuticals Secures FDA Alignment on Accelerated Approval Path for CRB-701 in Head and Neck and Cervical Cancer 1
  April 7, 2026
  

  Corbus Pharmaceuticals Announces FDA Alignment on Registrati...

• SS Innovations Hosts SMRSC 2026 in New Delhi Showcasing Advanced Surgical Robotics and Telesurgery Solutions
  April 7, 2026
  

  SS Innovations to Host Major Global Robotic Surgery Conferen...

• TransCode Therapeutics Secures Up to $20 Million Flexible Financing to Advance Lead Cancer Program and Extend Runway Into 2028
  April 7, 2026
  

  TransCode Therapeutics Secures Up to \$20 Million in Flexibl...

🔍 View more Reports